Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 5A pseudogene 3 (EIF5AP3) is a pseudogene, meaning it is a genomic DNA sequence similar to the functional EIF5A gene but does not encode a functional protein due to accumulated mutations or lack of regulatory elements[3]. Pseudogenes usually arise from gene duplication or retrotransposition events and are largely non-functional. While pseudogene transcripts can sometimes regulate the expression of their parent genes or other genes by means of competing endogenous RNA activity, EIF5AP3 is not recognized as having independent biological or therapeutic significance. The functional gene EIF5A, by contrast, encodes a unique translation factor involved in ribosome rescue and post-translational hypusination, but these activities do not extend to EIF5AP3[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 5A pseudogene 3 (EIF5AP3).